JP Morgan Chase’s Coya Therapeutics COYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.2K Sell
5,004
-177
-3% -$844 ﹤0.01% 6838
2026
Q2
$31.4K Buy
5,181
+181
+4% +$838 ﹤0.01% 6601
2026
Q1
$18.9K Hold
5,000
– – ﹤0.01% 6565
2025
Q4
$29K Hold
5,000
– – ﹤0.01% 6422
2025
Q3
$28.5K Buy
+5,000
New +$30.4K ﹤0.01% 6393
2025
Q1
– Sell
-32
Closed -$183 – 7370
2024
Q4
$183 Buy
32
+1
+3% +$7 ﹤0.01% 6924
2024
Q3
$200 Sell
31
-1
-3% -$6 ﹤0.01% 6905
2024
Q2
$194 Sell
32
-498
-94% -$4K ﹤0.01% 6791
2024
Q1
$5.26K Buy
530
+465
+715% +$3.64K ﹤0.01% 6443
2023
Q4
$482 Buy
65
+60
+1,200% +$333 ﹤0.01% 6934
2023
Q3
$19 Buy
+5
New +$20 ﹤0.01% 7173

Other funds holding COYA

JP Morgan Chase's COYA Position: Q3 2026 in Review

JP Morgan Chase reduced its Coya Therapeutics (COYA) stake by 3.4% in Q3 2026, selling an estimated $844 and leaving 5,004 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6838.

JP Morgan Chase first reported a position in COYA in Q3 2023 and has held it in 11 quarters since. The position peaked at $31.4K in Q2 2026. 52 funds tracked by Wall St. Rank hold COYA as of Q3 2026.

  • JP Morgan Chase held 5,004 shares of Coya Therapeutics worth $25.2K as of Q3 2026.
  • JP Morgan Chase sold 177 Coya Therapeutics shares in Q3 2026, an estimated $844.
  • Coya Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #6838 holding.
  • JP Morgan Chase first reported a position in Coya Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • JP Morgan Chase's Coya Therapeutics position peaked at $31.4K in Q2 2026.
  • 52 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.